These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21478119)

  • 81. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
    Mahmoudi M; Delhaye C; Wakabayashi K; Ben-Dor I; Gonzalez MA; Maluenda G; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2011 Jun; 107(12):1757-62. PubMed ID: 21497782
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
    de Winter RJ; Katagiri Y; Asano T; Milewski KP; Lurz P; Buszman P; Jessurun GAJ; Koch KT; Troquay RPT; Hamer BJB; Ophuis TO; Wöhrle J; Wyderka R; Cayla G; Hofma SH; Levesque S; Żurakowski A; Fischer D; Kośmider M; Goube P; Arkenbout EK; Noutsias M; Ferrari MW; Onuma Y; Wijns W; Serruys PW
    Lancet; 2018 Feb; 391(10119):431-440. PubMed ID: 29203070
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of chronic kidney disease on the efficacy of drug-eluting stents: long-term follow-up study.
    Osório Gomes V; Blaya P; Lasevitch R; Oliveira D; Hickmann P; Smidt L; Polanczyk C; Caramori P
    Arq Bras Cardiol; 2011 May; 96(5):346-51. PubMed ID: 21503391
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of Chronic Kidney Disease in Patients With Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New-Tokyo (MITO) Registry).
    Watanabe Y; Mitomo S; Naganuma T; Chieffo A; Montorfano M; Nakamura S; Colombo A
    Am J Cardiol; 2021 Jan; 138():33-39. PubMed ID: 33058802
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
    Zhu X; Zhang P; Xiong J; Wang N; Yang S; Zhu R; Zhang L; Liu W; Wu L
    Medicine (Baltimore); 2022 Nov; 101(44):e31498. PubMed ID: 36343078
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The Impact of Admission Serum Creatinine Derived Estimated Glomerular Filtration Rate on Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
    Uluganyan M; Karaca G; Ulutas TK; Ekmekci A; Tusun E; Murat A; Koroglu B; Uyarel H; Bakhshaliyev N; Eren M
    J Clin Med Res; 2016 Apr; 8(4):325-30. PubMed ID: 26985253
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of Everolimus-Eluting Stents on the Left Ventricular Systolic and Diastolic Functions.
    Parsaee MS; Nabati M; Saffar N; Taghavi M
    J Tehran Heart Cent; 2015 Apr; 10(2):93-7. PubMed ID: 26110008
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A preliminary experience report: Drug-eluting stents versus coronary artery bypass surgery in patients with a single lesion in the proximal left anterior descending artery suffering from diabetes mellitus and chronic stable angina.
    Toutouzas K; Patsa C; Vaina S; Tsiamis E; Vavuranakis M; Stefanadi E; Spanos A; Iliopoulos D; Panagiotou M; Chlorogiannis I; Pattakos E; Stefanadis C
    Hellenic J Cardiol; 2008; 49(2):65-71. PubMed ID: 18459462
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.
    Bavishi C; Baber U; Panwar S; Pirrotta S; Dangas GD; Moreno P; Tamis-Holland J; Kini AS; Sharma SK
    Int J Cardiol; 2017 Mar; 230():310-318. PubMed ID: 28062139
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The impact of new generation drug-eluting stent implantation on patients with chronic kidney disease and a single lesion in the proximal segment of the left anterior descending artery.
    Toutouzas K; Patsa C; Synetos A; Karanasos A; Karampelas J; Tsiamis E; Spanos A; Stefanadi E; Tousoulis D; Stefanadis C
    Hellenic J Cardiol; 2011; 52(2):103-10. PubMed ID: 21478119
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.